Boussard & Gavaudan Investment Management »

Halozyme Therapeutics shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $859k 22k 39.09
2023-03-31 $480k 13k 37.01

More positions owned by Boussard & Gavaudan Investment Management

Activision Blizzard
Horizon Therapeutics Pub L SHS
Chart Inds Note 1.000%11/1
Vmware Cl A Com
Seagen
Cnx Res Corp Note 2.250% 5/0
Booking Holdings Note 0.750% 5/0
Altair Engr Note 0.250% 6/0
Permian Resources Corp Note 3.250% 4/0
On Semiconductor Corp Note 5/0
Westrock (WRK)
Bgc Group Cl A (BGC)
Ambac Finl Group Com New (AMBC)
Cinemark Hldgs Note 4.500% 8/1
Dynavax Technologies Corp Note 2.500% 5/1

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Halozyme Therapeutics

Vanguard Group
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
Jennifer Ranahan
TD Asset Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Arrowpoint Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Bank of America Corporation
New York State Common Retirement Fund

View all funds holding Halozyme Therapeutics